🇺🇸 FDA
Patent

US 12171864

Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method

granted A61KA61K31/136A61K47/10

Quick answer

US patent 12171864 (Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method) held by SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/136, A61K47/10, A61K47/12, A61K47/14